Publicacións en colaboración con investigadores/as de Novartis (Sweden) (1)

2024

  1. Activity and safety of eltrombopag in combination with cyclosporin A as first‑line treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study

    The Lancet Haematology, Vol. 11, Núm. 3, pp. e206-e215